Dianthus Therapeutics | MGTA - Attività





Attività Cambiamento Data
Akebia Therapeutics USD 376.56M 12.41M 2025-12
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Avita Medical AUD 56.39M 1.74M 2025-12
Celltrion KRW 21.08T 530.63B 2025-09
Cspc Pharmaceutical CNY 46B 1.61B 2025-06
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
IQVIA Holdings USD 29.94B 1.22B 2025-12
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 1.05B 10.63M 2025-09
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 12.34B 203M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Organigram Holdings CAD 562.21M 2.4M 2025-09
Organon & Co USD 13.55B 52M 2025-09
Ovoca Bio EUR 11.41M 3.36M 2022-06
Pharma Mar EUR 395.08M 53.42M 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Revvity USD 12.17B 29.46M 2025-12
Sartorius EUR 9.61B 413.4M 2025-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tectonic Therapeutic USD 277M 18.31M 2025-09
Tilray USD 2.07B 1.33B 2025-03
Viatris USD 37.19B 727.3M 2025-12
Xeris Pharmaceuticals USD 370.19M 35.5M 2025-09
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09